
Use of the new 4-factor PCC, Beriplex
As of mid-2024, Australia’s prothrombin complex concentrate (PCC) has been replaced by the new 4-factor PCC (Factors II, VII, IX, X) BERIPLEX P/N (international plasma). From February 2025, the...
The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here